This article is more than 5 years old. Information may no longer be current.
Top stories in cardiology: Impurity-free angiotensin receptor antagonists identified, statin guidelines often not followed
Click Here to Manage Email Alerts
Among the top stories in cardiology last week were the FDA identifying more than three dozen angiotensin receptor antagonists that are impurity-free and data showing large discrepancies in the recommended use of statin therapy in patients with diabetes despite elevated risk.
Other popular stories included study findings that indicated any level of alcohol consumption was tied to increased BP and stroke risk in men, data that suggested premature death rates among Asian-American subgroups from CVD fluctuated and study results that showed artificial intelligence correctly recognized several cardiac rhythm devices. – by Janel Miller
FDA identifies 40 angiotensin receptor antagonists without impurities
The FDA announced that it has identified 40 angiotensin II receptor antagonists that do not contain any nitrosamine impurities that have been previously found in the active pharmaceutical ingredient in several lots of valsartan and losartan. Read more.
Guideline-recommended statin therapy use low in diabetes
NEW ORLEANS — There are significant gaps in the recommended use of statin therapy in patients with diabetes despite elevated risk, according to findings presented at the American College of Cardiology Scientific Session. Read more.
Moderate alcohol intake increases BP, stroke risk in men
In a genetic epidemiological study, the assumed protective effect of moderate alcohol consumption on CV events was noncausal, and any level of alcohol consumption was associated with increased BP and stroke risk in men. Read more.
CV mortality rate varies among Asian-American subgroups
Premature mortality due to CVD burden varies among Asian-American subgroups, and is highest in Asian Indian, Filipino and Vietnamese adults, according to findings published in the Journal of the American Heart Association. Read more.
Artificial intelligence accurately identifies cardiac rhythm devices
Artificial intelligence via a neural network exceeded human performance by accurately identifying the manufacturer and model of pacemakers and defibrillators in patients who underwent radiography, according to a study published in JACC: Clinical Electrophysiology. Read more.